Biotech | January 29, 2022
Israel signs deal to purchase Novavax’ Covid-19 vaccine
It would be the first protein-based alternative available in Israel
It would be the first protein-based alternative available in Israel
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
The award was given as a result of NASSCOM's meticulous screening process, in which over 700 start-ups were shortlisted as the most promising companies of the year
The vaccines are currently only authorised for emergency use in the country
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
